Response to: 'Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al' by Wei et al

Gossec, L.; Baraliakos, X.; McInnes, I.; Kerschbaumer, A.; Wit, M. de; Dougados, M.; ... ; Smolen, J.S. (2022)

Article / Letter to editor

• arthritis
• psoriatic
• biological therapy
• epidemiology

• All authors: Gossec, L.; Baraliakos, X.; McInnes, I.; Kerschbaumer, A.; Wit, M. de; Dougados, M.; Primdahl, J.; Heijde, D. van der; Smolen, J.S.
• Date: 2022-08-01
• Volume: 81
• Issue: 8
• DOI: doi:10.1136/annrheumdis-2020-218456
• Link: https://ard.bmj.com/content/81/8/e139